Axon Enterprise
AXON
$566.56
-5.69%
Axon Enterprise is a public safety technology company that integrates hardware devices and cloud software solutions, including TASER energy weapons, body cameras, drones, and digital evidence management, serving law enforcement and military clients. As a market leader in the public safety sector, Axon has established a dominant position with its connected devices and software ecosystem, differentiating itself through a hardware-first approach that leverages recurring software subscriptions. The current investor narrative centers on Axon's explosive growth in AI and drone technologies, which drove a strong Q1 2026 earnings beat and raised guidance, yet the stock remains down over 50% from its 52-week high, creating a debate about whether the market is mispricing its long-term potential or if the sell-off reflects overvaluation concerns. Recent headlines highlight both the optimism around AI-driven demand and the volatility in the stock price, with analysts maintaining bullish stances despite short-term market skepticism.…
AXON
Axon Enterprise
$566.56
Related headlines
Investment Opinion: Should I buy AXON Today?
Rating: Buy. Axon's explosive revenue growth, dominant market position, and improving profitability make it a compelling growth investment. The consensus 'Buy' rating and average target price of $693.40 (15.4% upside) support this view. Key data points: 33.75% YoY revenue growth, gross margin of 59.6%, net income of $169.3M in Q1, and forward PE of 56.89x. The stock is undervalued relative to its growth potential, as the PEG ratio is negative due to high growth expectations, but the PS premium of 557% over the sector is justified by its superior growth and market leadership.
Sign up to view all
AXON 12-Month Price Forecast
The AI assessment is bullish with medium confidence. Axon's strong revenue growth and improving profitability support a positive outlook, but the extreme valuation and high volatility warrant caution. The stock's significant decline from highs despite strong fundamentals suggests the market may be overly pessimistic, presenting a potential buying opportunity. However, if growth decelerates or margins fail to improve, the stock could face further downside. Key developments to watch include Q2 earnings, margin trends, and any competitive threats.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Axon Enterprise's 12-month outlook, with a consensus price target around $693.40 and implied upside of +22.4% versus the current price.
Average Target
$693.40
0 analysts
Implied Upside
+22.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$410 - $830
Analyst target range
Axon has coverage from 19 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.71 (where 1 is Strong Buy and 5 is Sell), indicating a bullish sentiment. The average target price is $693.40, implying an upside of 15.4% from the current price of $600.73, with a range from a low of $409.68 to a high of $830.00. The wide spread between the low and high targets suggests high uncertainty, with the low target potentially pricing in margin compression or competitive losses, while the high target assumes accelerating growth and multiple expansion. Recent institutional ratings show a pattern of reaffirmed Overweight and Buy ratings from firms like Piper Sandler, Needham, and Barclays, with no downgrades, indicating sustained analyst confidence in Axon's long-term prospects.
Bulls vs Bears: AXON Investment Factors
Axon presents a classic growth-versus-valuation debate. The bull case is compelling: 33.75% revenue growth, dominant market position, and strong analyst support. However, the bear case is equally strong: extreme valuation multiples, negative operating margins, and a stock that has lost half its value. Currently, the bull case has stronger evidence due to accelerating growth and improving profitability, but the key tension is whether the market will re-rate the stock higher or continue to punish its premium valuation. The resolution hinges on sustained revenue growth and margin expansion to justify the forward PE of 56.89x.
Bullish
- Explosive Revenue Growth: Q1 2026 revenue surged 33.75% YoY to $807.3M, accelerating sharply from the 12% growth in Q4 2025. This momentum is driven by strong demand for AI and drone technologies, indicating a robust product cycle.
- Dominant Market Position: Axon is the market leader in public safety technology with an integrated hardware-software ecosystem. Its recurring software subscriptions and high switching costs create a durable competitive moat, evidenced by a gross margin of 59.6%.
- Strong Analyst Conviction: With 19 analysts, consensus is 'Buy' (mean score 1.71) and average target price of $693.40 implies 15.4% upside. No recent downgrades, with firms like Piper Sandler and Barclays reaffirming Overweight/Buy ratings.
- Improving Profitability: Q1 2026 net income of $169.3M (net margin 21%) and EPS of $2.11 show a dramatic improvement from Q4 2025's near-breakeven. This demonstrates operating leverage and successful scaling of the business.
Bearish
- Extreme Valuation Premium: Trailing PE of 354.96x and PS of 16.43x vs. sector average 2.5x (557% premium) leave no room for error. Even forward PE of 56.89x implies high growth expectations that may be difficult to sustain.
- Stock Down 50% from Highs: Despite strong fundamentals, AXON trades 24.2% below its 52-week high of $792.16 and is down 23.17% over the past year. This suggests the market is skeptical of the valuation or growth sustainability.
- Negative Operating Margin: TTM operating margin is -2.23%, indicating core operations are not yet profitable. Heavy R&D spending ($188.95M in Q1) and SGA costs are pressuring margins, though net income is positive due to one-time items.
- High Volatility and Beta: Beta of 1.397 means the stock is 40% more volatile than the market, and the max drawdown of -60.28% highlights significant downside risk. Short interest ratio of 3.84 indicates bearish sentiment.
AXON Technical Analysis
Axon's price trend over the past year has been characterized by a significant downtrend, with the stock down 23.17% over the past year, yet it has shown a strong recovery from its 52-week low of $339.01. Currently trading at $600.73, the stock is positioned at 75.8% of its 52-week range (between $339.01 and $792.16), indicating a rebound from the lows but still below the highs. This positioning suggests the stock is in a recovery phase, with momentum building but not yet at overbought levels, as it remains 24.2% below the 52-week high of $792.16.
Beta
1.40
1.40x market volatility
Max Drawdown
-60.3%
Largest decline past year
52-Week Range
$339-$792
Price range past year
Annual Return
-24.2%
Cumulative gain past year
| Period | AXON Return | S&P 500 |
|---|---|---|
| 1m | +7.4% | +2.7% |
| 3m | +15.6% | +1.0% |
| 6m | -0.6% | +12.0% |
| 1y | -24.2% | +18.9% |
| ytd | +0.6% | +12.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXON Fundamental Analysis
Axon's revenue trajectory has been robust, with Q1 2026 revenue of $807.3 million, representing a 33.75% year-over-year growth rate, accelerating from the previous quarter's 12.0% growth (Q4 2025 revenue of $796.7 million). The multi-quarter trend shows consistent expansion, with revenue growing from $503.2 million in Q2 2024 to $807.3 million in Q1 2026, driven by strong demand for its connected devices and software solutions. The company's revenue segments, including Axon Body, Platform Solutions, and TASER X2, all contributed to growth, with the Software and Sensors segment generating $354.5 million in revenue, indicating a diversified product portfolio.
Quarterly Revenue
$807345000.0B
2026-03
Revenue YoY Growth
+33.8%
YoY Comparison
Gross Margin
59.1%
Latest Quarter
Free Cash Flow
$19507000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXON Overvalued?
Given Axon's positive net income of $169.3 million in Q1 2026, the PE ratio is the primary valuation metric, with a trailing PE of 354.96x and a forward PE of 56.89x, reflecting the market's expectation of significant earnings growth. The wide gap between trailing and forward PE implies that the market anticipates a substantial increase in earnings, which is supported by the company's strong revenue growth and improving profitability. Compared to the industry average, Axon's valuation is at a premium, with a PS ratio of 16.43x versus the sector average of 2.5x, indicating a 557% premium, which is justified by its superior growth and market position in the public safety technology niche.
PE
355.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 32x~170x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
236.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant. Axon's debt-to-equity ratio of 0.59 and interest expense of $28.6M in Q1 2026 indicate leverage that could strain cash flows if growth slows. The company's operating margin is negative at -2.23%, and free cash flow TTM is only $19.5M, suggesting limited internal funding for growth. Revenue concentration in the Connected Devices segment (majority of revenue) exposes the company to product-specific risks, and the high PS ratio of 16.43x implies that any revenue miss could trigger a sharp de-rating.
FAQ
The key risks are: 1) Valuation risk - the stock trades at a huge premium, and any growth disappointment could lead to a sharp de-rating. 2) Financial risk - negative operating margin and high debt-to-equity (0.59) could strain cash flows. 3) Market risk - high beta (1.397) means the stock is sensitive to market downturns. 4) Company-specific risk - dependence on government spending and potential competitive threats. The most severe risk is a growth slowdown, which could push the stock to the analyst low target of $409.68, a 32% downside.
The 12-month forecast is bullish, with a base case target of $693.40 (15.4% upside), a bull case of $830 (38% upside), and a bear case of $409.68 (32% downside). Probabilities are 30% bull, 50% base, and 20% bear. The most likely scenario is the base case, assuming revenue growth of 30%+ and margin improvement. The key assumption is that AI and drone demand continues to drive growth.
AXON is overvalued relative to its sector, with a PS ratio of 16.43x vs. the sector average of 2.5x, a 557% premium. However, this premium is justified by its superior growth (33.75% YoY) and market leadership. The forward PE of 56.89x suggests the market expects significant earnings growth, which is plausible given the improving net margin. The stock is fairly valued if growth continues at 30%+, but overvalued if growth decelerates.
AXON is a good buy for investors with a high risk tolerance and a long-term horizon. The stock offers 15.4% upside to the average analyst target of $693.40, supported by 33.75% revenue growth and a dominant market position. However, the extreme valuation (trailing PE of 354.96x) and high volatility (beta 1.397) mean it's not suitable for conservative investors. A good buy if you believe in the AI and drone growth story and can withstand significant price swings.
AXON is more suitable for long-term investment due to its high growth potential and volatility. The stock's beta of 1.397 and max drawdown of -60.28% make it risky for short-term trading. However, its strong revenue growth and market position suggest that a holding period of at least 3-5 years could allow the growth story to play out. Short-term traders may find opportunities in the stock's volatility, but the high valuation and market sensitivity make it a risky short-term play.